BlackRock Health Sciences Term Trust Proxy Filing

TL;DR

BlackRock Health Sciences Term Trust filed its proxy statement, shareholders vote soon.

AI Summary

BlackRock Health Sciences Term Trust is filing a Definitive Proxy Statement (DEFA14A) on May 24, 2024. This filing concerns the solicitation of proxies from shareholders. The company is located at 100 Bellevue Parkway, Wilmington, DE, 19809, and can be reached at 800-882-0052. The filing is not subject to a fee.

Why It Matters

This filing is important for shareholders as it details the information and proposals on which they will be asked to vote at the Trust's upcoming meeting.

Risk Assessment

Risk Level: low — This is a routine proxy filing, not indicating any unusual financial or operational risks.

Key Numbers

• 20240524 — Filing Date (Date the proxy statement was filed with the SEC.)

Key Players & Entities

• BlackRock Health Sciences Term Trust (company) — Registrant
• 100 Bellevue Parkway, Wilmington, DE, 19809 (company) — Business and Mail Address
• 800-882-0052 (company) — Business Phone
• BlackRock Health Sciences Trust II (company) — Former Company Name

FAQ

Filing Documents

• d802417ddefa14a.htm (DEFA14A) — 12KB
• g802417g01g01.jpg (GRAPHIC) — 458KB
• g802417g02g02.jpg (GRAPHIC) — 410KB
• 0001193125-24-147115.txt ( ) — 1209KB

From the Filing

HEALTH SCIENCES TERM TRUST BLACKROCK HEALTH SCIENCES TERM TRUST UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Definitive Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 BLACKROCK HEALTH SCIENCES TERM TRUST (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. YOUR Vote Matters BlackRock Health Sciences Term Trust (NYSE: BMEZ) BlackRock has taken shareholder-friendly actions across its closed-end funds to narrow discounts, enhance distributions and deliver long-term value. But activist hedge fund Saba Capital Management L.P. (Saba) is threatening your investment by attempting to oust the expert management that BlackRock provides. Vote today, defend your fundand your financial futurefrom falling into the wrong hands. Real actions have real impact. While 2022 was a challenging year, BlackRock has taken meaningful actions to drive significant performance improvements and substantial discount reductions. Total Market Price Return Discount to NAV Narrowing Fund v. Index Return 12/31/22 5/20/24 % Improvement 12/31/22 5/20/24 12/31/22 5/20/24 ECAT 19.19% 8.14% 57.58% 32.78% 19.36% BIGZ 22.79% 13.51% 40.72% 19.91% 1.16% BCAT 17.73% 7.75% 56.29% 25.18% 11.75% BMEZ 17.75% 12.67% 28.62% 10.28% 8.24% BSTZ 19.92% 14.19% 28.77% 26.70% 0.80% BFZ 14.72% 7.82% 46.88% 11.26% 7.28% MHN 12.30% 10.44% 15.12% 7.85% 3.88% MYN 13.27% 10.17% 23.36% 9.31% 5.33% BNY 13.19% 9.86% 25.25% 9.37% 5.39% MPA 14.52% 7.40% 49.04% 10.99% 7.02% What you need to do: Vote Defend today your . fund, save your income. BlackRock is fighting for YOU. Vote today ONLY on the WHITE proxy card: FOR the BlackRock Board nominees AGAINST Sabas proposal to terminate the investment management agreement with BlackRock IMPORTANT: DO NOT RETURN ANY GOLD CARD YOU RECEIVE FROM SABA. *Morningstar/BlackRock data as of 5/20/2024. Returns for time periods greater than 1 year are annualized. *Benchmarks for the funds are as follows: BIGZ (Russell 2500 Growth Index); BMEZ (MSCI Custom ACWI SMID Growth HC Call Overwrite Index); BSTZ (MSCI Custom ACWI SMID Growth IT Call Overwrite Index); BNY/MHN/MYN/MPA/BFZ (Bloomberg Municipal Bond Index); BCAT/ECAT (50% MSCI ACWI Index + 50% Bloomberg US AGG Bond Index) We ask that all shareholders vote on the enclosed WHITE proxy card today to preserve YOUR Fund: FOR the BlackRock Board nominees AGAINST Sabas proposal to terminate the investment management agreement with BlackRock How do I vote? Vote online Vote by phone Vote by mail Using the website provided By calling the toll-free By completing and on YOUR enclosed WHITE number on YOUR enclosed returning YOUR enclosed proxy card and following WHITE proxy card and WHITE card in the the simple instructions following the simple postage paid envelope instructions provided Please do NOT send back any proxy card you may receive from Saba If you have already sent back the proxy card received from Saba, you can still change your vote by promptly voting on the WHITE proxy card, which will replace the proxy card you previously completed. If you have any questions about the proposals to be voted, please feel free to contact Georgeson LLC (Georgeson), toll free at 1-866-529-4033. Important information about the Fund This material is not an advertisement and is intended for existing shareholder use only. This document and the information contained herein relates solely to BlackRock Health Sciences Term Trust (BMEZ). The information contained herein does not relate to, and is not relevant to, any other fund or product sponsored or distributed by BlackRock or any of its affiliates. This document is not an offer to sell any securities and is not a solicitation of an offer to buy any securities. Common shares for the closed-end fund identified above are only available for purchase and sale at current market price on a stock exchange. A closed-end funds dividend yield, market price and NAV will fluctuate with market conditions. The information for this Fund is provided for informational purposes only and does not constitute a solicitation of an offer to buy or sell Fund shares. Performance results reflect past performance and are no guarantee of future results. Current performance may be lower or higher than the performance data quoted. All returns assume reinvestment of all dividends. The market value and net asset value (NAV) of a funds shares wi

View Full Filing

View this DEFA14A filing on SEC EDGAR